Immunoglobulin NGS enhance residual disease detection and prognosis in pediatric Ph+ acute lymphoblastic leukemia.

Front Immunol · 2025 · PMC12907345 · PMID 41704536

Europe PMC DOI

hedged sentences

0.0600

closest p · 1.2× alpha

0.0700

boldest claim

The sentences

did not reach statistical significancep = 0.06so close (0.05 < p ≤ 0.1)

Five-years RFS also trended higher among FCM MRD negative patients but did not reach statistical significance (69% vs. 38%, p = 0.06; Figure 4D ).

also in 111,027 other papers

showed a trendp = 0.07so close (0.05 < p ≤ 0.1)

While IGHJ4 gene usage was not associated with significant differences in prognosis (p = 0.37; Figure 2D ), patients harboring IGHJ6 gene showed a trend towards inferior five-years RFS (p = 0.07; Figure 2E ).

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.